Antioxidants and other pharmacological treatments for Friedreich ataxia

Mary Kearney, Richard W Orrell, Michael Collingwood Fahey, Massimo Pandolfo

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Friedreich ataxia is a rare inherited, autosomal recessive, neurological disorder characterised initially by unsteadiness in standing and walking, slowly progressing to wheelchair dependency usually in the late teens or early twenties. It is associated with slurred speech, scoliosis, pes cavus and heart abnormalities which may cause premature death in 60 to 80 of people. There is no easily defined clinical or biochemical marker and no known treatment.
Original languageEnglish
Pages (from-to)1 - 27
Number of pages27
JournalCochrane Database of Systematic Reviews
Volume2009
Issue numberCD007791
DOIs
Publication statusPublished - 2009

Cite this

Kearney, Mary ; Orrell, Richard W ; Fahey, Michael Collingwood ; Pandolfo, Massimo. / Antioxidants and other pharmacological treatments for Friedreich ataxia. In: Cochrane Database of Systematic Reviews. 2009 ; Vol. 2009, No. CD007791. pp. 1 - 27.
@article{c9c412093d00491291a21d2645c9d539,
title = "Antioxidants and other pharmacological treatments for Friedreich ataxia",
abstract = "Friedreich ataxia is a rare inherited, autosomal recessive, neurological disorder characterised initially by unsteadiness in standing and walking, slowly progressing to wheelchair dependency usually in the late teens or early twenties. It is associated with slurred speech, scoliosis, pes cavus and heart abnormalities which may cause premature death in 60 to 80 of people. There is no easily defined clinical or biochemical marker and no known treatment.",
author = "Mary Kearney and Orrell, {Richard W} and Fahey, {Michael Collingwood} and Massimo Pandolfo",
year = "2009",
doi = "10.1002/14651858.CD007791.pub2.",
language = "English",
volume = "2009",
pages = "1 -- 27",
journal = "Cochrane Database of Systematic Reviews",
issn = "1469-493X",
publisher = "John Wiley & Sons",
number = "CD007791",

}

Antioxidants and other pharmacological treatments for Friedreich ataxia. / Kearney, Mary; Orrell, Richard W; Fahey, Michael Collingwood; Pandolfo, Massimo.

In: Cochrane Database of Systematic Reviews, Vol. 2009, No. CD007791, 2009, p. 1 - 27.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Antioxidants and other pharmacological treatments for Friedreich ataxia

AU - Kearney, Mary

AU - Orrell, Richard W

AU - Fahey, Michael Collingwood

AU - Pandolfo, Massimo

PY - 2009

Y1 - 2009

N2 - Friedreich ataxia is a rare inherited, autosomal recessive, neurological disorder characterised initially by unsteadiness in standing and walking, slowly progressing to wheelchair dependency usually in the late teens or early twenties. It is associated with slurred speech, scoliosis, pes cavus and heart abnormalities which may cause premature death in 60 to 80 of people. There is no easily defined clinical or biochemical marker and no known treatment.

AB - Friedreich ataxia is a rare inherited, autosomal recessive, neurological disorder characterised initially by unsteadiness in standing and walking, slowly progressing to wheelchair dependency usually in the late teens or early twenties. It is associated with slurred speech, scoliosis, pes cavus and heart abnormalities which may cause premature death in 60 to 80 of people. There is no easily defined clinical or biochemical marker and no known treatment.

UR - http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD007791/frame.html

U2 - 10.1002/14651858.CD007791.pub2.

DO - 10.1002/14651858.CD007791.pub2.

M3 - Article

VL - 2009

SP - 1

EP - 27

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1469-493X

IS - CD007791

ER -